top of page

ATHENA
BEVACIZUMAB PLUS CHEMOTHERAPY IN LOCALLY RECURRENT OR METASTATIC BREAST CANCER

CLINICAL TRIAL DETAILS
BEVACIZUMAB PLUS CHEMOTHERAPY IN LOCALLY RECURRENT OR METASTATIC BREAST CANCER.
-
COUNTRY
STATUS
TUMOR TYPE
PHASE
N
SITES
BREAST
15
120.0
II
Spain
SETUP
TRIAL OVERVIEW
PRESS RELEASE
SCIENTIFIC IMPACT
-
BLOG ARTICLES RELATED
-
TRIAL SITES
-
Dr. Sofia Braga
Dr. Silvi AntolÃn
Dr. Escrivá de RomanÃ
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley
bottom of page
